-
EU MDR Article 61 Clinical Evaluation
The European Union (EU) Medical Device Regulation 2017/745 (EU MDR) aims to ensure a high level of...
-
Challenges of Demonstrating Biological Equivalence per ISO 10993-18 and EU MDR
In the European Union (EU), a device is considered equivalent if it fulfills all the requirements of...
-
Regulatory Challenges for Novel Implantable Devices under EU MDR
In the European Union (EU), the Medical Device Regulation (EU MDR) has replaced the Medical Device Directive...
-
A Quick Guide to the EU IVDR
The In Vitro Diagnostic Directive (EU) 98/79/EC (IVDD) was introduced over two decades ago to establish the...
-
Navigating Biocompatibility: An Introduction to ISO 10993 Series of Standards
Medical device manufacturers should always refer to ISO 10993 Series of Standards in addition to region-specific regulatory...
-
FDA’s New Guidance on Nitrosamine and Nitrosamine- Drug Substance Related Impurities and Recommended Acceptable Intake Limits
The FDA has recently published a Recommended Acceptable Limit guidance document for nitrosamine impurities in drug products....
-
Navigating the Complex World of PFAS Regulation for Medical Devices
Per- and poly-fluoroalkyl substances (PFAS) are a group of fluorinated compounds characterized by carbon-fluorine bonds. While some...
-
An important downside to eSTAR
If you are keeping abreast of FDA’s medical device efforts, then you know that as of October...
-
ISO 10993-17 Revision
The new version of ISO 10993-17 is expected to be published very soon. This is a major...
-
Can the safe history of clinical use be used as justification for biocompatibility of a medical device?
Can the safe history of clinical use (no complaints registered in PMS) be used as justification not...